317 related articles for article (PubMed ID: 17059347)
1. Antioxidative and modifying effects of a tropical plant Azadirachta indica (Neem) on azoxymethane-induced preneoplastic lesions in the rat colon.
Arakaki J; Suzui M; Morioka T; Kinjo T; Kaneshiro T; Inamine M; Sunagawa N; Nishimaki T; Yoshimi N
Asian Pac J Cancer Prev; 2006; 7(3):467-71. PubMed ID: 17059347
[TBL] [Abstract][Full Text] [Related]
2. Modifying effects of Terminalia catappa on azoxymethane-induced colon carcinogenesis in male F344 rats.
Morioka T; Suzui M; Nabandith V; Inamine M; Aniya Y; Nakayama T; Ichiba T; Yoshimi N
Eur J Cancer Prev; 2005 Apr; 14(2):101-5. PubMed ID: 15785313
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of extract of leaves of ginkgo (Ginkgo biloba) and its component bilobalide on azoxymethane-induced colonic aberrant crypt foci in rats.
Suzuki R; Kohno H; Sugie S; Sasaki K; Yoshimura T; Wada K; Tanaka T
Cancer Lett; 2004 Jul; 210(2):159-69. PubMed ID: 15183531
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of crude alpha-mangostin, a xanthone derivative, on two different categories of colon preneoplastic lesions induced by 1, 2-dimethylhydrazine in the rat.
Nabandith V; Suzui M; Morioka T; Kaneshiro T; Kinjo T; Matsumoto K; Akao Y; Iinuma M; Yoshimi N
Asian Pac J Cancer Prev; 2004; 5(4):433-8. PubMed ID: 15546251
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of a flavonoid myricitrin on the formation of azoxymethane-induced premalignant lesions in colons of rats.
Asano N; Kuno T; Hirose Y; Yamada Y; Yoshida K; Tomita H; Nakamura Y; Mori H
Asian Pac J Cancer Prev; 2007; 8(1):73-6. PubMed ID: 17477776
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats.
Miyamoto S; Kohno H; Suzuki R; Sugie S; Murakami A; Ohigashi H; Tanaka T
Oncol Rep; 2006 May; 15(5):1169-73. PubMed ID: 16596181
[TBL] [Abstract][Full Text] [Related]
7. The modifying effect of Peucedanum japonicum, a herb in the Ryukyu Islands, on azoxymethane-induced colon preneoplastic lesions in male F344 rats.
Morioka T; Suzui M; Nabandith V; Inamine M; Aniya Y; Nakayama T; Ichiba T; Mori H; Yoshimi N
Cancer Lett; 2004 Mar; 205(2):133-41. PubMed ID: 15036645
[TBL] [Abstract][Full Text] [Related]
8. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of dietary monoglucosylceramide 1-O-beta-glucosyl-N-2'-hydroxyarachidoyl-4,8-sphingadienine on two different categories of colon preneoplastic lesions induced by 1,2-dimethylhydrazine in F344 rats.
Inamine M; Suzui M; Morioka T; Kinjo T; Kaneshiro T; Sugishita T; Okada T; Yoshimi N
Cancer Sci; 2005 Dec; 96(12):876-81. PubMed ID: 16367907
[TBL] [Abstract][Full Text] [Related]
11. Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract.
Metz N; Lobstein A; Schneider Y; Gossé F; Schleiffer R; Anton R; Raul F
Nutr Cancer; 2000; 38(1):60-4. PubMed ID: 11341046
[TBL] [Abstract][Full Text] [Related]
12. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats.
Verghese M; Rao DR; Chawan CB; Shackelford L
J Nutr; 2002 Sep; 132(9):2804-8. PubMed ID: 12221249
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane.
Yoshimi N; Shimizu M; Matsunaga K; Yamada Y; Fujii K; Hara A; Mori H
Jpn J Cancer Res; 1999 Apr; 90(4):406-12. PubMed ID: 10363578
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of beta-catenin and KRAS expressions by Piper betle in azoxymethane-induced colon cancer of male Fischer 344 rats.
Esa F; Ngah WZ; Jamal AR; Mohd Yusof YA
Anal Quant Cytopathol Histpathol; 2013 Dec; 35(6):324-34. PubMed ID: 24617038
[TBL] [Abstract][Full Text] [Related]
15. Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence.
Raju J; Swamy MV; Cooma I; Patlolla JM; Pittman B; Reddy BS; Steele VE; Rao CV
Int J Cancer; 2005 Feb; 113(5):798-802. PubMed ID: 15499611
[TBL] [Abstract][Full Text] [Related]
16. Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats.
Kohno H; Suzuki R; Noguchi R; Hosokawa M; Miyashita K; Tanaka T
Jpn J Cancer Res; 2002 Feb; 93(2):133-42. PubMed ID: 11856476
[TBL] [Abstract][Full Text] [Related]
17. Prevention of the development of preneoplastic lesions, aberrant crypt foci, by a water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia in male F344 rats.
Lu H; Uesaka T; Katoh O; Kyo E; Watanabe H
Oncol Rep; 2001; 8(6):1341-5. PubMed ID: 11605062
[TBL] [Abstract][Full Text] [Related]
18. Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis.
Femia AP; Dolara P; Caderni G
Carcinogenesis; 2004 Feb; 25(2):277-81. PubMed ID: 14604897
[TBL] [Abstract][Full Text] [Related]
19. Regressive effects of various chemopreventive agents on azoxymethane-induced aberrant crypt foci in the rat colon.
Morishita Y; Yoshimi N; Kawabata K; Matsunaga K; Sugie S; Tanaka T; Mori H
Jpn J Cancer Res; 1997 Sep; 88(9):815-20. PubMed ID: 9369928
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of Coptidis Rhizoma and Scutellariae Radix on azoxymethane-induced aberrant crypt foci formation in rat colon.
Fukutake M; Yokota S; Kawamura H; Iizuka A; Amagaya S; Fukuda K; Komatsu Y
Biol Pharm Bull; 1998 Aug; 21(8):814-7. PubMed ID: 9743248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
